{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T23:11:52Z","timestamp":1793142712139,"version":"4.5.0"},"reference-count":64,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T00:00:00Z","timestamp":1726617600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Gut Microbes"],"published-print":{"date-parts":[[2024,12,31]]},"DOI":"10.1080\/19490976.2024.2402550","type":"journal-article","created":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T16:41:47Z","timestamp":1726677707000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":21,"title":["End-to-end donor screening and manufacturing controls: complementary quality-based strategies to minimize patient risk for donor-derived microbiome therapeutics"],"prefix":"10.1080","volume":"16","author":[{"given":"Jason","family":"Goldsmith","sequence":"first","affiliation":[{"name":"Product Development, Quality, and Supply (PDQS), Seres Therapeutics, Inc., Cambridge, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Tomkovich","sequence":"additional","affiliation":[{"name":"Product Development, Quality, and Supply (PDQS), Seres Therapeutics, Inc., Cambridge, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John G.","family":"Auni\u0146\u0161","sequence":"additional","affiliation":[{"name":"Product Development, Quality, and Supply (PDQS), Seres Therapeutics, Inc., Cambridge, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara H.","family":"McGovern","sequence":"additional","affiliation":[{"name":"Product Development, Quality, and Supply (PDQS), Seres Therapeutics, Inc., Cambridge, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer C.","family":"Mahoney","sequence":"additional","affiliation":[{"name":"Product Development, Quality, and Supply (PDQS), Seres Therapeutics, Inc., Cambridge, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brooke R.","family":"Hasson","sequence":"additional","affiliation":[{"name":"Product Development, Quality, and Supply (PDQS), Seres Therapeutics, Inc., Cambridge, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher W J","family":"McChalicher","sequence":"additional","affiliation":[{"name":"Product Development, Quality, and Supply (PDQS), Seres Therapeutics, Inc., Cambridge, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S.","family":"Ege","sequence":"additional","affiliation":[{"name":"Product Development, Quality, and Supply (PDQS), Seres Therapeutics, Inc., Cambridge, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2024,9,18]]},"reference":[{"key":"e_1_3_4_2_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2106516"},{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-016-0298-8"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI72336"},{"key":"e_1_3_4_5_1","unstructured":"FDA. Information pertaining to additional safety protections regarding use of fecal microbiota for transplantation - screening donors for COVID-19 and exposure to SARS-Cov-2 and testing for SARS-Cov-2 [Internet]. 2020 [accessed 2022 Jul 18]. https:\/\/www.fda.gov\/Vaccines-Blood-Biologics\/Safety-Availability-Biologics\/Information-Pertaining-Additional-Safety-Protections-Regarding-Use-Fecal-Microbiota-Transplantation-1."},{"key":"e_1_3_4_6_1","unstructured":"FDA. Safety alert regarding use of fecal microbiota for transplantation and additional safety protections pertaining to monkeypox virus [Internet]. 2022. https:\/\/www.fda.gov\/vaccines-blood-biologics\/safety-availability-biologics\/safety-alert-regarding-use-fecal-microbiota-transplantation-and-additional-safety-protections-0."},{"key":"e_1_3_4_7_1","unstructured":"FDA. Safety alert regarding use of fecal microbiota for transplantation and risk of serious adverse events likely due to transmission of pathogenic organisms [Internet]. 2020 [accessed 2022 Jul 18]. https:\/\/www.fda.gov\/vaccines-blood-biologics\/safety-availability-biologics\/safety-alert-regarding-use-fecal-microbiota-transplantation-and-risk-serious-adverse-events-likely."},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.1002503"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMe1913807"},{"key":"e_1_3_4_10_1","first-page":"2111","volume-title":"Gut","volume":"68","author":"Cammarota G","year":"2019","unstructured":"Cammarota G, Ianiro G, Kelly CR, Mullish BH, Allegretti JR, Kassam Z, Putignani L, Fischer M, Keller JJ, Costello SP, et al. International consensus conference on stool banking for faecal microbiota transplantation in clinical practice. Gut; Vol. 68. 2019. p. 2111."},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2018-316818"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/apt.13868"},{"key":"e_1_3_4_13_1","unstructured":"Inc FP. Rebyota [package insert]. US food and drug administration website [internet]. 2024. https:\/\/www.fda.gov\/vaccines-blood-biologics\/vaccines\/rebyota."},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-21-0324"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.130848"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa1486"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/apt.13746"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1017\/dmp.2015.137"},{"key":"e_1_3_4_20_1","unstructured":"CDC. Outbreak cases and data [Internet]. 2023 [accessed 2023 Aug 25]. 2022. https:\/\/www.cdc.gov\/poxvirus\/mpox\/response\/2022\/index.html."},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0025691"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tmrv.2023.150769"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1910437"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2020.01.018"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.3201\/eid2608.200681"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.14309\/ctg.0000000000000343"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2666-5247(21)00059-8"},{"key":"e_1_3_4_28_1","unstructured":"FDA. ICH Q5A (R2)[Internet]. https:\/\/www.fda.gov\/media\/163115\/download."},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biologicals.2022.10.002"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/1751-7915.14074"},{"key":"e_1_3_4_31_1","unstructured":"CDC. Symptoms of Non-Polio Enterovirus Infection | CDC. 2021. https:\/\/www.cdc.gov\/non-polio-enterovirus\/about\/symptoms.html."},{"key":"e_1_3_4_32_1","unstructured":"CDC. Enterovirus D68 (EV-D68) | CDC. 2021. https:\/\/www.cdc.gov\/non-polio-enterovirus\/about\/ev-d68.html."},{"key":"e_1_3_4_33_1","unstructured":"CDC. About non-polio enteroviruses | CDC. 2021. https:\/\/www.cdc.gov\/non-polio-enterovirus\/index.html."},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.24933"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.1890050305"},{"key":"e_1_3_4_36_1","unstructured":"CDC. Polio vaccine: vaccine-derived poliovirus. 2021. https:\/\/www.cdc.gov\/vaccines\/vpd\/polio\/hcp\/vaccine-derived-poliovirus-faq.html."},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/0195-6701(90)90090-B"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.1018594"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.12688\/wellcomeopenres.15628.3"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro.2016.83"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2019.12.025"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.15252\/msb.202010116"},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34502-3"},{"key":"e_1_3_4_44_1","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.9966"},{"key":"e_1_3_4_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2016.07.019"},{"key":"e_1_3_4_46_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2022.815422"},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2019.00034"},{"key":"e_1_3_4_48_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.53570"},{"key":"e_1_3_4_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jadr.2022.100355"},{"key":"e_1_3_4_50_1","doi-asserted-by":"publisher","DOI":"10.1080\/10253890.2019.1617267"},{"key":"e_1_3_4_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpr.2020.101943"},{"key":"e_1_3_4_52_1","doi-asserted-by":"publisher","DOI":"10.1097\/MNH.0000000000000293"},{"key":"e_1_3_4_53_1","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.115.05315"},{"key":"e_1_3_4_54_1","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2017.00381"},{"key":"e_1_3_4_55_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.62.10.1097"},{"key":"e_1_3_4_56_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2017.4602"},{"key":"e_1_3_4_57_1","unstructured":"DSM-5 criteria for major depressive disorder [Internet]. [cited 2021 Apr 26]. https:\/\/www.mdcalc.com\/dsm-5-criteria-major-depressive-disorder."},{"key":"e_1_3_4_58_1","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aba8555"},{"key":"e_1_3_4_59_1","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.2177"},{"key":"e_1_3_4_60_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0276323"},{"key":"e_1_3_4_61_1","doi-asserted-by":"publisher","DOI":"10.4315\/0362-028X-72.12.2565"},{"key":"e_1_3_4_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vetpar.2013.01.049"},{"key":"e_1_3_4_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijfoodmicro.2012.03.017"},{"key":"e_1_3_4_64_1","unstructured":"FDA in brief: FDA warns about potential risk of serious infections caused by multi-drug resistant organisms related to the investigational use of fecal microbiota for transplantation [Internet]. [accessed 2021 Mar 1]. https:\/\/www.fda.gov\/news-events\/fda-brief\/fda-brief-fda-warns-about-potential-risk-serious-infections-caused-multi-drug-resistant-organisms."},{"key":"e_1_3_4_65_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-020-03858-z"},{"key":"e_1_3_4_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(20)30473-4"}],"container-title":["Gut Microbes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/19490976.2024.2402550","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,16]],"date-time":"2024-12-16T13:36:08Z","timestamp":1734356168000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/19490976.2024.2402550"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,18]]},"references-count":64,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,12,31]]}},"alternative-id":["10.1080\/19490976.2024.2402550"],"URL":"https:\/\/doi.org\/10.1080\/19490976.2024.2402550","relation":{},"ISSN":["1949-0976","1949-0984"],"issn-type":[{"value":"1949-0976","type":"print"},{"value":"1949-0984","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,18]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=kgmi20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=kgmi20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-06-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-08-26","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-09-04","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-09-18","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2402550"}}